Aberrant methylation and loss of CADM2 tumor suppressor expression is associated with human renal cell carcinoma tumor progression

Biochemical and Biophysical Research Communications

Volumn 435, Issue 4, 2013, Pages 526-532

  He, Wei ^a,b   Li, Xuesong ^a,b   Xu, Shuping ^c   Ai, Junkui ^c   Gong, Yanqing ^a,b   Gregg, Jennifer L ^c   Guan, Ruili ^a,b   Qiu, Wei ^a,b   Xin, Dianqi ^a,b   Gingrich, Jeffrey R ^c   Guo, Yinglu ^a,b   Chang, Guimin ^c  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b NATIONAL UROLOGICAL CANCER CENTER   (China)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

CADM2; Methylation; Renal cell carcinoma; Tumor suppressor

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CELL ADHESION MOLECULE 2; GENOMIC DNA; LENTIVIRUS VECTOR; SMALL INTERFERING RNA; TRICHOSTATIN A; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CARCINOMA CELL; CELL ANCHORAGE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; COLONY FORMATION; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION; GENE REPRESSION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; KIDNEY CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR INVASION; TUMOR XENOGRAFT; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANIMALS; CARCINOMA, RENAL CELL; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL PROLIFERATION; DNA METHYLATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; MICE; MICE, INBRED BALB C;

LENTIVIRUS;

EID: 84878983840     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.04.074     Document Type: Article

References (17)

1. Bastien L., et al. Targeted therapies in metastatic renal cancer in 2009. BJU Int. 2009, 103:1334-1342.
2. Siegel R., et al. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J. Clin. 2011, 61:212-236.
3. Basso M., et al. A survey of therapy for advanced renal cell carcinoma. Urol. Oncol. 2010, 28:121-133.
4. Kuramochi M., et al. TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer. Nat. Genet. 2001, 27:427-430.
5. Williams Y.N., et al. Cell adhesion and prostate tumor-suppressor activity of TSLL2/IGSF4C, an immunoglobulin superfamily molecule homologous to TSLC1/IGSF4. Oncogene 2006, 25:1446-1453.
6. Chang G., et al. Hypoexpression and epigenetic regulation of candidate tumor suppressor gene CADM-2 in human prostate cancer. Clin. Cancer Res. 2010, 16:5390-5401.
7. Cody N.A., et al. Characterization of the 3p12.3-pcen region associated with tumor suppression in a novel ovarian cancer cell line model genetically modified by chromosome 3 fragment transfer. Mol. Carcinog. 2009, 48:1077-1092.
8. Lake S.L., et al. Whole-genome microarray detects deletions and loss of heterozygosity of chromosome 3 occurring exclusively in metastasizing uveal melanoma. Invest. Ophthalmol. Vis. Sci. 2010, 51:4884-4891.
9. Roy D., et al. Tumor suppressor genes FHIT and WWOX are deleted in primary effusion lymphoma (PEL) cell lines. Blood 2011, 118:e32-39.
10. Hansel D.E. Genetic alterations and histopathologic findings in familial renal cell carcinoma. Histol. Histopathol. 2006, 21:437-444.
11. Powell C.A., et al. Loss of heterozygosity in epithelial cells obtained by bronchial brushing: clinical utility in lung cancer. Clin. Cancer Res. 1999, 5:2025-2034.
12. Li L.C., Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002, 18:1427-1431.
13. Sidransky D. Nucleic acid-based methods for the detection of cancer. Science 1997, 278:1054-1059.
14. Xiong Y., et al. Histone deacetylase inhibitors decrease DNA methyltransferase-3B messenger RNA stability and down-regulate de novo DNA methyltransferase activity in human endometrial cells. Cancer Res. 2005, 65:2684-2689.
15. Harma V., et al. A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses. PLoS ONE 2010, 5:e10431.
16. He B., et al. Tetraspanin CD82 attenuates cellular morphogenesis through down-regulating integrin alpha6-mediated cell adhesion. J. Biol. Chem. 2005, 280:3346-3354.
17. Mizutani K., et al. Interaction of nectin-like molecule 2 with integrin alpha6beta4 and inhibition of disassembly of integrin alpha6beta4 from hemidesmosomes. J. Biol. Chem. 2011, 286:36667-36676.